DZ270A1 - Nouveau procédé d'enrobage d'au moins un principe actif midécamenteux, les nouveaux médivaments ainsi obtenus et les compositions les renfermant. - Google Patents
Nouveau procédé d'enrobage d'au moins un principe actif midécamenteux, les nouveaux médivaments ainsi obtenus et les compositions les renfermant.Info
- Publication number
- DZ270A1 DZ270A1 DZ816110A DZ816110A DZ270A1 DZ 270 A1 DZ270 A1 DZ 270A1 DZ 816110 A DZ816110 A DZ 816110A DZ 816110 A DZ816110 A DZ 816110A DZ 270 A1 DZ270 A1 DZ 270A1
- Authority
- DZ
- Algeria
- Prior art keywords
- active principle
- coating
- new
- principle
- amentous
- Prior art date
Links
- 239000011248 coating agent Substances 0.000 title abstract 3
- 238000000576 coating method Methods 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 4
- 239000007787 solid Substances 0.000 abstract 4
- 238000013019 agitation Methods 0.000 abstract 2
- 239000006185 dispersion Substances 0.000 abstract 2
- 230000002209 hydrophobic effect Effects 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8004199A FR2476485A1 (fr) | 1980-02-26 | 1980-02-26 | Nouveau procede d'enrobage d'au moins un principe actif medicamenteux, les nouveaux medicaments ainsi obtenus, et les compositions les renfermant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DZ270A1 true DZ270A1 (fr) | 2004-09-13 |
Family
ID=9238982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DZ816110A DZ270A1 (fr) | 1980-02-26 | 1981-02-25 | Nouveau procédé d'enrobage d'au moins un principe actif midécamenteux, les nouveaux médivaments ainsi obtenus et les compositions les renfermant. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0036345B1 (cs) |
| JP (1) | JPS56133214A (cs) |
| AT (1) | ATE4957T1 (cs) |
| CA (1) | CA1163923A (cs) |
| DE (1) | DE3161148D1 (cs) |
| DZ (1) | DZ270A1 (cs) |
| FR (1) | FR2476485A1 (cs) |
| MA (1) | MA19084A1 (cs) |
| OA (1) | OA06747A (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4912146A (en) * | 1985-01-30 | 1990-03-27 | Warner-Lambert Company | Coated dosage forms |
| US4971791A (en) * | 1985-08-26 | 1990-11-20 | The Procter & Gamble Company | Taste masking compositions |
| US4874613A (en) * | 1987-03-06 | 1989-10-17 | Baker Cummins Pharmaceuticals, Inc. | Taste concealing pharmaceutical dosage unit |
| DE4328069A1 (de) * | 1993-08-20 | 1995-02-23 | Henning Berlin Gmbh | Mikropartikel, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln |
| ITPD20070274A1 (it) * | 2007-08-08 | 2009-02-09 | Sanypet S P A | Crocchetta per animali e metodo per la sua produzione |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2010110A1 (de) * | 1970-03-04 | 1971-09-16 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von Mikrokapseln mit Hilfe von synthetischen Koazervaten |
| US3922379A (en) * | 1973-12-17 | 1975-11-25 | Abbott Lab | Microencapsulation process |
| LU72439A1 (cs) * | 1975-05-09 | 1977-02-09 | ||
| JPS5394274A (en) * | 1977-01-29 | 1978-08-18 | Ricoh Co Ltd | Micro-encapsulating method |
-
1980
- 1980-02-26 FR FR8004199A patent/FR2476485A1/fr active Granted
-
1981
- 1981-02-17 OA OA57330A patent/OA06747A/xx unknown
- 1981-02-20 DE DE8181400274T patent/DE3161148D1/de not_active Expired
- 1981-02-20 EP EP81400274A patent/EP0036345B1/fr not_active Expired
- 1981-02-20 AT AT81400274T patent/ATE4957T1/de not_active IP Right Cessation
- 1981-02-25 DZ DZ816110A patent/DZ270A1/fr active
- 1981-02-25 MA MA19288A patent/MA19084A1/fr unknown
- 1981-02-25 CA CA000371719A patent/CA1163923A/fr not_active Expired
- 1981-02-26 JP JP2621481A patent/JPS56133214A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| OA06747A (fr) | 1982-06-30 |
| DE3161148D1 (en) | 1983-11-17 |
| FR2476485B1 (cs) | 1983-03-04 |
| ATE4957T1 (de) | 1983-10-15 |
| JPS56133214A (en) | 1981-10-19 |
| FR2476485A1 (fr) | 1981-08-28 |
| JPH0530805B2 (cs) | 1993-05-11 |
| CA1163923A (fr) | 1984-03-20 |
| EP0036345B1 (fr) | 1983-10-12 |
| EP0036345A1 (fr) | 1981-09-23 |
| MA19084A1 (fr) | 1981-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2331375A1 (fr) | Procede pour l'obtention de preparations avec liberation reglee d'un principe actif | |
| AU3808478A (en) | Treatment of thromboembolic conditions withall-z)-5, 8, 11, 14, 17-eicosapentaenoic acid | |
| EP0068450A3 (en) | Pharmaceutical forms for oral administration | |
| DZ270A1 (fr) | Nouveau procédé d'enrobage d'au moins un principe actif midécamenteux, les nouveaux médivaments ainsi obtenus et les compositions les renfermant. | |
| ATE26213T1 (de) | Aeusserlich anzuwendende arzneimittelzubereitung enthaltend adenosin zur behandlung von herpes. | |
| FR2429787A1 (fr) | Nouveaux derives de l'acide thiazol-2-oxamique substitues en position 4, leur preparation et leur utilisation en tant que medicaments | |
| OA06201A (fr) | Procédé de préparation de nouveaux composés d'urée et amido . | |
| DK0380950T3 (da) | Fremgangsmåde til fremstilling af et bismuthbaseret præparat samt det aktive produkt i præparat | |
| FR2532647B1 (fr) | Thioesters d'acide acetylsalicylique, procede pour les preparer et compositions pharmaceutiques qui en renferment | |
| JPS5781411A (en) | Medicinal composition having antiviral action | |
| FR2522266B1 (fr) | Procede de preparation d'un agent fibrinolytiquement actif et agent obtenu | |
| FR2392022A1 (fr) | Procede pour la preparation d'un complexe soluble dans l'eau de 2-(4'-thiazolyl)benzimidazole et pour la preparation de compositions anthelmintiques et fongicides | |
| DE2963545D1 (en) | Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation | |
| BE878836A (fr) | Derives d'acide hydroxamique, leur procede de preparation et medicament les contenant | |
| FR2368490A1 (fr) | Nouveaux derives de l'acide clavulanique, leur preparation et compositions pharmaceutiques en contenant | |
| JPS54132520A (en) | Preparation of colorless methionine | |
| PT77767B (fr) | Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant | |
| FR2355839A1 (fr) | Derives optiquement actifs d'acide benzoxazolyl-propionique, procede pour leur preparation et compositions therapeutiques les contenant | |
| ZA803765B (en) | Process for the preparation of an agent which contains organic, cyclic compounds with keto and/or hydroxyl groups and surface active agents, and processes for the production of pulp using this agent | |
| ES531260A0 (es) | Procedimiento de preparar agentes farmaceuticos bactericidas utilizables contra la rinitis atrofica. | |
| PT64821B (fr) | Procede pour la preparation d'esteres pirimidin(2)iliques de l'acide thionophosphorique a effet insecticide et acaricide. | |
| FR2460111B2 (fr) | Composition a base d'un melange aqueux de n-methyl-2-pyrrolidone et d'acide 2-halogenethylphosphonique et son application au traitement de plantes | |
| FR2430949A1 (fr) | Nouvelles 4h-s-triazolo (3,4c) thieno (2,3e) 1,4-diazepines, procedes pour leur preparation et medicaments les renfermant | |
| PT67907A (fr) | Procede pour la preparation de 2'-hydroxy-2 d'addition d'acides et compositions pharmaceutiques qui les contiennent. | |
| JPS6410A (en) | Phoxim emulsion resistant to discoloration and production thereof |